Kairos as indeterminate risk management: The pharmaceutical industry's response to bioterrorism

  • Blake Scott J
  • 17


    Mendeley users who have this article in their library.
  • 22


    Citations of this article.


The pharmaceutical industry's response to the threat of bioterrorism following 9-11 invoked the rhetorical notion of kairos as an urgent and ongoing opportunity not only to protect the nation but also to improve the industry's reputation and fortify its political power. Yet the notion of kairos as seizing an advantage—grounded in modernist assumptions about agency and control—is also complicated by the case history of big pharma's response, which left the industry vulnerable to heightened and additional risks. This case history suggests that kairos can be less about seizing an advantage than about indeterminately responding to shifting, unbounded, uncertain, unpredictable, and uncontrollable risks shaped by the processes of globalization.

Author-supplied keywords

  • Bioterrorism
  • Globalization
  • Kairos
  • Pharmaceutical
  • Risk

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • J. Blake Scott

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free